Standard treatment of vulvovaginal candidiasis relies on antimycotics such as clotrimazole and miconazole, yet recurrences remain common, highlighting the need for more durable therapies. This master’s thesis aimed to develop antimycotic-loaded nanofibers and explore their potential combined use with a model probiotic strain to support restoration of the vaginal microbiota.
We prepared hydrophilic nanofibers from poly(acrylic acid) (PAA) and hydrophobic nanofibers from poly(caprolactone) (PCL). First, we evaluated the bacteriostatic effects of clotrimazole and miconazole on the model probiotic strain Lactobacillus jensenii ATCC 25258, neither of which fully inhibited bacterial growth. Based on these findings, clotrimazole was selected for incorporation into PAA and PCL nanofibers. In the case of PAA nanofibers, we also evaluated probiotic viability in polymer–clotrimazole dispersions suitable for potential co-incorporation. PAA showed bactericidal activity, making simultaneous incorporation infeasible; therefore, only clotrimazole-loaded PAA nanofibers were developed.
For the development of nanofibers containing 5% (m/m) clotrimazole, we optimized the formulation and processing parameters for electrospinning. The optimal dispersions were 7,5% (m/V) PAA in an aqueous solution containing 0,1% (m/V) Tween 80, and 13,5% (m/V) PCL dissolved in a 3:1 (V/V) mixture of formic and acetic acid. The morphology of the resulting nanofibers was evaluated by scanning electron microscopy. To improve their stability in aqueous media, PAA nanofibers were additionally crosslinked with 100 mM iron (III) chloride. The stability of crosslinked PAA and PCL nanofibers in water was assessed by mass loss measurements, where PAA nanofibers lost up to 36% of their mass after 24 h, whereas PCL nanofibers lost only 8%. We aimed to quantify the incorporation efficiency of clotrimazole and its release into modified simulated vaginal fluid using high-performance liquid chromatography. For this purpose, we developed the method; however, we found that clotrimazole is not stable in modified simulated vaginal fluid and undergoes degradation, preventing quantitative evaluation of its release in this medium. Nevertheless, the developed PAA and PCL nanofibers loaded with clotrimazole represent a promising system for the local treatment of vulvovaginal candidiasis, provided that suitable analytical approaches for evaluating release kinetics are further optimized.
|